Microarrayer Shop Aushon BioSystems Closes $7.8M in Series A Financing | GenomeWeb
NEW YORK (GenomeWeb News) — Microarrayer developer Aushon BioSystems has raised $7.8 million in a Series A financing round, the company said today.
 
Financing company North Bridge Venture Partners led the round, which ended on Oct. 12, Aushon said.
 
The early stage company, based in Burlington, Mass., makes microarrayers for protein, antibody, and cell research. Its clients include the National Institutes of Health, M.D. Anderson Cancer Center, and George Mason University.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The White House has created a list of cuts, including to the NIH, that could be in a budget bill for this year.

The US National Institutes of Health is to allow applicants to cite preprints just as they would any other research paper, ScienceInsider reports.

Two manuscript pages handwritten by Charles Darwin are going on the auction block, according to the Los Angeles Times.

In PNAS this week: tool to track transcriptome-wide binding, evidence of balancing selection on behavior-linked genes, and more.